4.6 Article

The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors

期刊

PLOS ONE
卷 8, 期 6, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0068020

关键词

-

资金

  1. Else Kroner-Fresenius Stiftung, Germany

向作者/读者索取更多资源

Human bocavirus is the second autonomous human parvovirus with assumed pathogenic potential. Other parvoviruses are known to persist and even integrate into the host genome, eventually contributing to the multi-step development of cancer. Human bocavirus also persists in an unknown percentage of clinically asymptomatic patients in addition to those with primary infection. The aim of the present study was to analyze the role of Human bocavirus in lung and colorectal cancers. Therefore, formalin-fixed, paraffin-embedded, archived tumor samples were screened for Human bocavirus DNA by PCR, Southern blotting, and sequencing. Positive tissues were further subjected to fluorescence in situ hybridization analysis to specifically detect human bocavirus DNA in the infected cells. In total, 11 of the 60 (18.3%) lung and 9 of the 44 (20.5%) colorectal tumors tested positive for human bocavirus DNA by PCR and were confirmed by sequencing and fluorescence in situ hybridization analysis. Thus, human bocavirus DNA is present in the nuclei of infected cells, in either single or multiple copies, and appears to form concatemers. The occurrence of these human bocavirus DNA structures supports the existence of the postulated sigma- or rolling-hairpin replication mechanism. Moreover, the fluorescence in situ hybridization patterns inspired the hypothesis that human bocavirus DNA either persists as cccDNA or is integrated into the host genome. This finding suggests that this virus may indirectly contribute to the development of some colorectal and lung cancers, as do other DNA viruses, such as the human hepatitis B virus, or may play an active role in cancer by interacting with the host genome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

Umberto Malapelle, Pasquale Pisapia, Antonino Iaccarino, Massimo Barberis, Claudio Bellevicine, Hans Brunnstrom, Dario de Biase, Giovanna De Maglio, Kajsa Ericson Lindquist, Matteo Fassan, Gabriella Fontanini, Elisa Gruppioni, Paul Hofman, Sabine Merkelbach-Bruse, Miguel A. Molina Vila, Anais Pujals, Ida Rapa, Luisella Righi, Rafael Rosell, Oliver Schildgen, Verena Schildgen, Fernando C. Schmitt, Giovanni Tallini, Sara Vander Borght, Elena Vigliar, Marco Volante, Svenja Wagener-Ryczek, Birgit Weynand, Giancarlo Troncone

Summary: The workload of molecular testing for patients with advanced-stage lung cancer during the lockdown showed little variations. Local strategies to overcome health emergency-related issues included the preference for RT-PCR tissue-based testing methodologies and, occasionally, for liquid biopsy.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Ophthalmology

Detection of Coronavirus in Tear Samples of Hospitalized Patients With Confirmed SARS-CoV-2 From Oropharyngeal Swabs

R. Michael Dutescu, Peter Banasik, Oliver Schildgen, Norbert Schrage, Daniel Uthoff

Summary: This study found a higher percentage of coronavirus RNA in tears of SARS-CoV-2 positive patients using tear fluid sampling technique similar to oropharyngeal lavage compared to earlier reports using conjunctival swabs. Although patients in intensive care showed ocular symptoms, viral conjunctivitis was not observed in any patients.

CORNEA (2021)

Letter Public, Environmental & Occupational Health

Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)

Jessica Luesebrink, Verena Schildgen, Oliver Schildgen

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2021)

Article Medicine, General & Internal

Differential cytology profiles in bronchoalveolar lavage (BAL) in COVID-19 patients A descriptive observation and comparison with other corona viruses, Influenza virus, Haemophilus influenzae, and Pneumocystis jirovecii

Vanessa Vedder, Verena Schildgen, Jessica Lusebrink, Ramona Liza Tillmann, Birgitta Domscheit, Wolfram Windisch, Christian Karagiannidis, Michael Brockmann, Oliver Schildgen

Summary: The study compared the cytological profiles of BALs from patients infected with various respiratory pathogens, finding that different pathogens caused distinct cell pattern changes but no general cell distribution pattern. Although the cytology pattern of BAL fluid is not specific enough to be used as the sole diagnostic criterion for COVID-19, it may support clinical decision-making.

MEDICINE (2021)

Article Microbiology

Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective

Verena Schildgen, Sabrina Demuth, Jessica Luesebrink, Oliver Schildgen

Summary: This study analyzed the performance of three different rapid antigen tests in a clinical setting, showing varying specificities and sensitivities which did not entirely meet all expectations. Therefore, careful evaluation is needed when considering their benefits for specific testing strategies and settings.

PATHOGENS (2021)

Letter Anesthesiology

Perioperative risk evaluation in patients scheduled for elective surgery in close relation to their SARS-CoV-2 vaccination

Ulrich Limper, Jerome Defosse, Oliver Schildgen, Frank Wappler

BRITISH JOURNAL OF ANAESTHESIA (2021)

Letter Infectious Diseases

False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden

Andreas Kretschmer, Annelene Kossow, Barbara Gruene, Oliver Schildgen, Tim Mathes, Verena Schildgen

JOURNAL OF INFECTION (2022)

Letter Infectious Diseases

Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way out

Verena Schildgen, Jessica Luesebrink, Oliver Schildgen

JOURNAL OF INFECTION (2023)

Letter Infectious Diseases

The Takara SARS-CoV-2 direct PCR detection kit delivers reliable results with throat wash specimens

M. Nitsch, T. Stahlhut, O. Schildgen, V. Schildgen

NEW MICROBES AND NEW INFECTIONS (2022)

Letter Infectious Diseases

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)

Verena Schildgen, Jessica Luesebrink, Oliver Schildgen

NEW MICROBES AND NEW INFECTIONS (2022)

Letter Respiratory System

High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery

Matthias Obenaus, Oliver Schildgen, Dirk Schuermann, Ann-Christin von Bruenneck, Martin Janz, Ulrich Keller, Bernhard Gebauer, Johannes Schilling, Stefan Schwartz, Benedikt Weissbrich, Thomas Schneider, Joerg Hofmann, Stephan Mathas

ERJ OPEN RESEARCH (2021)

Letter Infectious Diseases

Low sensitivity of SARS-CoV-2 rapid antigen self-tests under laboratory conditions

S. Demuth, S. Damaschek, O. Schildgen, V. Schildgen

Summary: European strategies on SARS-CoV-2 antigen testing focus on rapid tests conducted by healthcare professionals and self-tests, but evidence shows weak performance even under laboratory conditions.

NEW MICROBES AND NEW INFECTIONS (2021)

暂无数据